These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 35459189)

  • 1. PEDF is an antifibrosis factor that inhibits the activation of fibroblasts in a bleomycin-induced pulmonary fibrosis rat model.
    Qin X; Jia C; Liang J; Chen J; Liu X; Chao Z; Qin H; Yuan Y; Liu Z; Zhang Z; Dong H; Zhang H
    Respir Res; 2022 Apr; 23(1):100. PubMed ID: 35459189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curdione ameliorates bleomycin-induced pulmonary fibrosis by repressing TGF-β-induced fibroblast to myofibroblast differentiation.
    Liu P; Miao K; Zhang L; Mou Y; Xu Y; Xiong W; Yu J; Wang Y
    Respir Res; 2020 Feb; 21(1):58. PubMed ID: 32075634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
    Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
    Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P311 Promotes Lung Fibrosis via Stimulation of Transforming Growth Factor-β1, -β2, and -β3 Translation.
    Duan FF; Barron G; Meliton A; Mutlu GM; Dulin NO; Schuger L
    Am J Respir Cell Mol Biol; 2019 Feb; 60(2):221-231. PubMed ID: 30230348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing lncRNA Snhg6 mitigates bleomycin-induced pulmonary fibrosis in mice via miR-26a-5p/TGF-β1-smads axis.
    Deng W; Zhang Y; Fang P; Shi H; Yang S
    Environ Toxicol; 2022 Oct; 37(10):2375-2387. PubMed ID: 35785413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
    Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
    Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zanubrutinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β1 signaling pathway.
    Chen S; Wei Y; Li S; Miao Y; Gu J; Cui Y; Liu Z; Liang J; Wei L; Li X; Zhou H; Yang C
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109316. PubMed ID: 36252483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective role of rhapontin in experimental pulmonary fibrosis in vitro and in vivo.
    Tao L; Cao J; Wei W; Xie H; Zhang M; Zhang C
    Int Immunopharmacol; 2017 Jun; 47():38-46. PubMed ID: 28364627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.
    Mou F; Mou C
    Med Sci Monit; 2020 Feb; 26():e919739. PubMed ID: 32019905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming interferon (IFN)-γ resistance ameliorates transforming growth factor (TGF)-β-mediated lung fibroblast-to-myofibroblast transition and bleomycin-induced pulmonary fibrosis.
    Chang CJ; Lin CF; Lee CH; Chuang HC; Shih FC; Wan SW; Tai C; Chen CL
    Biochem Pharmacol; 2021 Jan; 183():114356. PubMed ID: 33285108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis.
    Cosgrove GP; Brown KK; Schiemann WP; Serls AE; Parr JE; Geraci MW; Schwarz MI; Cool CD; Worthen GS
    Am J Respir Crit Care Med; 2004 Aug; 170(3):242-51. PubMed ID: 15117744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indirubin alleviates bleomycin-induced pulmonary fibrosis in mice by suppressing fibroblast to myofibroblast differentiation.
    Wang Q; Yu J; Hu Y; Chen X; Zhang L; Pan T; Miao K; Mou Y; Xu Y; Xiong W; Wang Y
    Biomed Pharmacother; 2020 Nov; 131():110715. PubMed ID: 32927253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIM33 prevents pulmonary fibrosis by impairing TGF-β1 signalling.
    Boutanquoi PM; Burgy O; Beltramo G; Bellaye PS; Dondaine L; Marcion G; Pommerolle L; Vadel A; Spanjaard M; Demidov O; Mailleux A; Crestani B; Kolb M; Garrido C; Goirand F; Bonniaud P
    Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32184320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.
    Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased deposition of chondroitin/dermatan sulfate glycosaminoglycan and upregulation of β1,3-glucuronosyltransferase I in pulmonary fibrosis.
    Venkatesan N; Ouzzine M; Kolb M; Netter P; Ludwig MS
    Am J Physiol Lung Cell Mol Physiol; 2011 Feb; 300(2):L191-203. PubMed ID: 21056957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
    Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
    PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing FHL2 inhibits bleomycin-induced pulmonary fibrosis through the TGF-β1/Smad signaling pathway.
    Shi M; Cui H; Shi J; Mei Y
    Exp Cell Res; 2023 Feb; 423(2):113470. PubMed ID: 36641135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipose-derived mesenchymal stem cell therapy for reverse bleomycin-induced experimental pulmonary fibrosis.
    Zhao X; Wu J; Yuan R; Li Y; Yang Q; Wu B; Zhai X; Wang J; Magalon J; Sabatier F; Daumas A; Zhu WM; Zhu N
    Sci Rep; 2023 Aug; 13(1):13183. PubMed ID: 37580529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of HtrA3 Attenuates Bleomycin-Induced Pulmonary Fibrosis Via TGF-β1/Smad Signaling Pathway.
    Li G; Shen C; Wei D; Yang X; Jiang C; Yang X; Mao W; Zou J; Tan J; Chen J
    Lung; 2023 Apr; 201(2):235-242. PubMed ID: 36823409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ajulemic acid exerts potent anti-fibrotic effect during the fibrogenic phase of bleomycin lung.
    Lucattelli M; Fineschi S; Selvi E; Garcia Gonzalez E; Bartalesi B; De Cunto G; Lorenzini S; Galeazzi M; Lungarella G
    Respir Res; 2016 May; 17(1):49. PubMed ID: 27153807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.